Development of a multi-targeted chemotherapeutic approach based on G-quadruplex stabilisation and carbonic anhydrase inhibition
Alessio Nocentini Anna Di Porzio Alessandro Bonardi Carla Bazzicalupi Andrea Petreni Tarita Biver Silvia Bua Simona Marzano Jussara Amato Bruno Pagano Nunzia Iaccarino Stefano De Tito Stefano Amente Claudiu T. Supuran Antonio Randazzo Paola Gratteri a NEUROFARBA Department,Pharmaceutical and Nutraceutical Section and Laboratory of Molecular Modeling Cheminformatics & QSAR,University of Florence,Sesto Fiorentino,Florence,Italyb Department of Pharmacy,University of Naples Federico II,Naples,Italyc Department of Chemistry "Ugo Schiff",University of Florence,Sesto Fiorentino,Florence,Italyd Department of Chemistry and Industrial Chemistry,University of Pisa,Pisa,Italye Research Institute of the University of Bucharest (ICUB),Bucharest,Romaniaf Molecular Cell Biology of Autophagy,The Francis Crick Institute,London,UKg Department of Molecular Medicine and Medical Biotechnologies,University of Naples Federico II,Naples,Italy
DOI: https://doi.org/10.1080/14756366.2024.2366236
2024-06-19
Journal of Enzyme Inhibition and Medicinal Chemistry
Abstract:A novel class of compounds designed to hit two anti-tumour targets, G-quadruplex structures and human carbonic anhydrases (hCAs) IX and XII is proposed. The induction/stabilisation of G-quadruplex structures by small molecules has emerged as an anticancer strategy, disrupting telomere maintenance and reducing oncogene expression. hCAs IX and XII are well-established anti-tumour targets, upregulated in many hypoxic tumours and contributing to metastasis. The ligands reported feature a berberine G-quadruplex stabiliser scaffold connected to a moiety inhibiting hCAs IX and XII. In vitro experiments showed that our compounds selectively stabilise G-quadruplex structures and inhibit hCAs IX and XII. The crystal structure of a telomeric G-quadruplex in complex with one of these ligands was obtained, shedding light on the ligand/target interaction mode. The most promising ligands showed significant cytotoxicity against CA IX-positive HeLa cancer cells in hypoxia, and the ability to stabilise G-quadruplexes within tumour cells.
biochemistry & molecular biology,chemistry, medicinal